Drug Development

Drug Development

Psychiatric Drug Development: Diagnosing a Crisis

When it comes to funding drug research to treat depression, schizophrenia, anxiety, and other psychiatric disorders, the global pharmaceutical industry prefers to invest its research dollars in cancer, metabolism, autoimmunity, and other disease areas. This comes despite the fact that one in five Americans currently take at least one psychiatric drug and that mental disorders are recognized worldwide. The author traces the evolution of psychiatric drug development, the reasons for its retreat, and what needs to change to meet the growing demand.

Drug Development

The Long, Sometimes Bumpy Road of Drug Development

The current arduous process of drug development may be improved through brain imaging.

Drug Development

Transforming Drug Development Through Brain Imaging

After years of research and enormous expense, perhaps only one in a hundred potential drugs for a brain disorder will receive government approval and make it to the person who needs it. Neuroimaging may change this dramatically.